Fortune February 1, 2024
Katrina Compoli, Bloomberg

WW International Inc. suffered its worst month on record in January, erasing the wellness company’s advance since it said in March that it was entering the growing market for a new class of weight-loss drugs.

WW, better known as WeightWatchers, slumped 6.1% on Wednesday, bringing its decline for the month to 57% amid emerging competition and concern around subscriber growth. The latest drop came as part of a broad market slide Wednesday after Federal Reserve Chair Jerome Powell signaled officials aren’t rushing to cut interest rates.

The performance is a stark reversal from 2023. The stock notched its biggest one-day gain since 2015 on March 7 after WW struck a deal for telehealth obesity-drug provider Sequence. Enthusiasm around the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech, Provider, Wellness
Primary Care That’s Incentivized To Keep People Healthy
“People will seek wellness, peace and healing” – Reading the GWI Future of Wellness Report, 2024 Trends
10 states with the best health & wellness
Peloton Picks Apple Fitness+ Vet Peter Stern as New CEO
How gen AI is revolutionizing the fitness industry

Share This Article